Jpmorgan Chase & CO 10x Genomics, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 355,488 shares of TXG stock, worth $5.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
355,488
Previous 78,133 354.98%
Holding current value
$5.07 Million
Previous $1.52 Million 428.37%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
BUY
$15.71 - $23.49 $4.36 Million - $6.52 Million
277,355 Added 354.98%
355,488 $8.03 Million
Q3 2024

Nov 08, 2024
BUY
$15.71 - $23.49 $4.36 Million - $6.52 Million
277,355 Added 354.98%
355,488 $8.03 Million
Q2 2024

Dec 26, 2024
SELL
$19.45 - $37.37 $5.39 Million - $10.4 Million
-277,355 Reduced 78.02%
78,133 $1.52 Million
Q2 2024

Aug 12, 2024
SELL
$19.45 - $37.37 $25,304 - $48,618
-1,301 Reduced 1.64%
78,133 $1.52 Million
Q1 2024

Dec 26, 2024
SELL
$36.08 - $54.3 $9.96 Million - $15 Million
-276,054 Reduced 77.65%
79,434 $2.98 Million
Q1 2024

May 10, 2024
SELL
$36.08 - $54.3 $50.4 Million - $75.8 Million
-1,395,852 Reduced 94.62%
79,434 $2.98 Million
Q4 2023

Dec 26, 2024
BUY
$34.32 - $57.55 $38.4 Million - $64.4 Million
1,119,798 Added 315.0%
1,475,286 $82.6 Million
Q4 2023

Feb 12, 2024
BUY
$34.32 - $57.55 $8.34 Million - $14 Million
243,124 Added 19.73%
1,475,286 $82.6 Million
Q3 2023

Nov 14, 2023
SELL
$40.86 - $62.98 $4.54 Million - $7 Million
-111,170 Reduced 8.28%
1,232,162 $50.8 Million
Q2 2023

Aug 11, 2023
BUY
$50.96 - $58.72 $3.6 Million - $4.15 Million
70,597 Added 5.55%
1,343,332 $75 Million
Q1 2023

May 18, 2023
BUY
$35.33 - $55.79 $1.89 Million - $2.98 Million
53,411 Added 4.38%
1,272,735 $71 Million
Q1 2023

May 11, 2023
SELL
$35.33 - $55.79 $1.5 Million - $2.38 Million
-42,576 Reduced 3.37%
1,219,324 $68 Million
Q4 2022

Feb 13, 2023
BUY
$24.4 - $41.3 $1.35 Million - $2.29 Million
55,496 Added 4.6%
1,261,900 $46 Million
Q3 2022

Nov 14, 2022
BUY
$28.48 - $52.59 $5.6 Million - $10.3 Million
196,482 Added 19.46%
1,206,404 $34.4 Million
Q2 2022

Aug 11, 2022
BUY
$36.95 - $82.41 $34.2 Million - $76.3 Million
926,161 Added 1105.72%
1,009,922 $45.7 Million
Q1 2022

May 11, 2022
SELL
$55.7 - $145.79 $3.54 Million - $9.27 Million
-63,593 Reduced 43.16%
83,761 $6.37 Million
Q4 2021

Feb 10, 2022
SELL
$135.05 - $182.59 $10.8 Million - $14.6 Million
-80,199 Reduced 35.24%
147,354 $22 Million
Q3 2021

Nov 12, 2021
BUY
$145.58 - $192.14 $33.1 Million - $43.7 Million
227,553 New
227,553 $33.1 Million

Others Institutions Holding TXG

# of Institutions
293
Shares Held
98.2M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.35B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email